Development of electrocardiogram intervals during growth of FVB/N neonate mice

BMC Physiology

Volumn 10, Issue 1, 2010, Pages

  Heier, Christopher R ^a,b   Hampton, Thomas G ^c   Wang, Deli ^b   Didonato, Christine J ^a,b  

^a CHILDREN S MEMORIAL RESEARCH CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Mouse Specifics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; ELECTROCARDIOGRAPHY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEART RATE; MALE; METHODOLOGY; MOUSE; NEWBORN; PHYSIOLOGY; RANDOMIZATION; SEX DIFFERENCE; STATISTICAL MODEL;

ANIMALS; ANIMALS, NEWBORN; AUTONOMIC NERVOUS SYSTEM; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; LOGISTIC MODELS; MALE; MICE; RANDOM ALLOCATION; SEX FACTORS;

EID: 77955813928     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-10-16     Document Type: Article

References (47)

1. Prevalence of congenital heart disease. JI Hoffman S Kaplan RR Liberthson, Am Heart J 2004 147 3 425 439 10.1016/j.ahj.2003.05.003 14999190
2. The incidence of arrhythmias in a pediatric cardiac intensive care unit. TM Hoffman G Wernovsky TS Wieand MI Cohen AC Jennings VL Vetter RI Godinez JW Gaynor TL Spray LA Rhodes, Pediatr Cardiol 2002 23 6 598 604 10.1007/s00246-001-0079-y 12530491
3. Interventional electrophysiology in patients with congenital heart disease. EP Walsh, Circulation 2007 115 25 3224 3234 10.1161/CIRCULATIONAHA.106. 655753 17592091
4. Mechanisms by which SCN5A mutation N1325 S causes cardiac arrhythmias and sudden death in vivo. XL Tian SL Yong X Wan L Wu MK Chung PJ Tchou DS Rosenbaum DR Van Wagoner GE Kirsch Q Wang, Cardiovasc Res 2004 61 2 256 267 10.1016/j.cardiores.2003.11.007 14736542
5. Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A. K Hong A Berruezo-Sanchez N Poungvarin A Oliva M Vatta J Brugada P Brugada JA Towbin R Dumaine C Pinero-Galvez,, et al. J Cardiovasc Electrophysiol 2004 15 1 64 69 10.1046/j.1540-8167.2004.03341.x 15028074
6. The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death - the Brugada syndrome. J Brugada P Brugada R Brugada, Europace 1999 1 3 156 166 10.1053/eupc.1999.0033 11225790
7. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Q Wang ME Curran I Splawski TC Burn JM Millholland TJ VanRaay J Shen KW Timothy GM Vincent T de Jager,, et al. Nat Genet 1996 12 1 17 23 10.1038/ng0196-17 8528244
8. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Q Wang J Shen I Splawski D Atkinson Z Li JL Robinson AJ Moss JA Towbin MT Keating, Cell 1995 80 5 805 811 10.1016/0092-8674(95)90359-3 7889574
9. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. K Poetter H Jiang S Hassanzadeh SR Master A Chang MC Dalakas I Rayment JR Sellers L Fananapazir ND Epstein, Nat Genet 1996 13 1 63 69 10.1038/ng0596-63 8673105
10. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. L Thierfelder H Watkins C MacRae R Lamas W McKenna HP Vosberg JG Seidman CE Seidman, Cell 1994 77 5 701 712 10.1016/0092-8674(94)90054-X 8205619
11. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy. P Carango JE Noble HG Marks VL Funanage, Genomics 1993 18 2 340 348 10.1006/geno.1993.1474 8288237
12. Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR. MW Kilimann A Pizzuti M Grompe CT Caskey, Hum Genet 1992 89 3 253 258 10.1007/BF00220535 1601417
13. Mouse models of SCN5A-related cardiac arrhythmias. F Charpentier A Bourge J Merot, Prog Biophys Mol Biol 2008 98 2-3 230 237 10.1016/j.pbiomolbio.2008. 10.012 19041666
14. Changes in function of cardiac receptors mediating the effects of the autonomic nervous system in the muscular dystrophy (MDX) mouse. S Lu A Hoey, J Mol Cell Cardiol 2000 32 1 143 152 10.1006/jmcc.1999.1063 10652198
15. Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy. V Chu JM Otero O Lopez MF Sullivan JP Morgan I Amende TG Hampton, Muscle Nerve 2002 26 4 513 519 10.1002/mus.10223 12362417
16. Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy. TP Maddatu SM Garvey DG Schroeder TG Hampton GA Cox, Hum Mol Genet 2004 13 11 1105 1115 10.1093/hmg/ddh129 15069027
17. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. M Arad IP Moskowitz VV Patel F Ahmad AR Perez-Atayde DB Sawyer M Walter GH Li PG Burgon CT Maguire,, et al. Circulation 2003 107 22 2850 2856 10.1161/01.CIR.0000075270. 13497.2B 12782567
18. Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. V Gaussin GE Morley L Cox A Zwijsen KM Vance L Emile Y Tian J Liu C Hong D Myers,, et al. Circ Res 2005 97 3 219 226 10.1161/01.RES.0000177862.85474.63 16037571
19. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. BG Bruneau G Nemer JP Schmitt F Charron L Robitaille S Caron DA Conner M Gessler M Nemer CE Seidman,, et al. Cell 2001 106 6 709 721 10.1016/S0092-8674(01)00493-7 11572777
20. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. IP Moskowitz JB Kim ML Moore CM Wolf MA Peterson J Shendure MA Nobrega Y Yokota C Berul S Izumo,, et al. Cell 2007 129 7 1365 1376 10.1016/j.cell.2007.04.036 17604724
21. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. H Kasahara H Wakimoto M Liu CT Maguire KL Converso T Shioi WY Huang WJ Manning D Paul J Lawitts,, et al. J Clin Invest 2001 108 2 189 201 11457872
22. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. H Watanabe N Chopra D Laver HS Hwang SS Davies DE Roach HJ Duff DM Roden AA Wilde BC Knollmann, Nat Med 2009 15 4 380 383 10.1038/nm.1942 19330009
23. Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents. EL Piatnitski Chekler JA Butera L Di RE Swillo GA Morgan EI Rossman C Huselton BD Larsen JK Hennan, Bioorg Med Chem Lett 2009 19 16 4551 4554 10.1016/j.bmcl.2009.07.014 19616941
24. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. XH Wehrens SE Lehnart SR Reiken SX Deng JA Vest D Cervantes J Coromilas DW Landry AR Marks, Science 2004 304 5668 292 296 10.1126/science.1094301 15073377
25. Age-dependent response of the electrocardiogram to K(+) channel blockers in mice. L Wang S Swirp H Duff, Am J Physiol Cell Physiol 2000 278 1 73 80 10644514
26. Phenotypic screening for heart rate variability in the mouse. J Gehrmann PE Hammer CT Maguire H Wakimoto JK Triedman CI Berul, Am J Physiol Heart Circ Physiol 2000 279 2 733 740 10924073
27. Use of telemetry to record electrocardiogram and heart rate in freely moving mice. K Kramer SA van Acker HP Voss JA Grimbergen WJ van der Vijgh A Bast, J Pharmacol Toxicol Methods 1993 30 4 209 215 10.1016/1056-8719(93)90019-B 8123902
28. Measurement of heart rate and Q-T interval in the conscious mouse. GF Mitchell A Jeron G Koren, Am J Physiol 1998 274 3 Pt 2 747 751 9530184
29. Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice. O Stiedl J Spiess, Behav Neurosci 1997 111 4 703 711 10.1037/0735-7044.111.4.703 9267648
30. Method for non-invasively recording electrocardiograms in conscious mice. V Chu JM Otero O Lopez JP Morgan I Amende TG Hampton, BMC Physiol 2001 1 6 10.1186/1472-6793-1-6 11476671
31. A collaborative database of inbred mouse strain characteristics. SC Grubb GA Churchill MA Bogue, Bioinformatics 2004 20 16 2857 2859 10.1093/ bioinformatics/bth299 15130929
32. Genetic influence on electrocardiogram time intervals and heart rate in aging mice. S Xing SW Tsaih R Yuan KL Svenson LM Jorgenson M So BJ Paigen R Korstanje, Am J Physiol Heart Circ Physiol 2009 296 6 1907 1913 10.1152/ajpheart.00681.2008 19395551
33. Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice. V Shusterman I Usiene C Harrigal JS Lee T Kubota AM Feldman B London, Am J Physiol Heart Circ Physiol 2002 282 6 2076 2083 12003814
34. The pNNx Heart Rate Variability Statistics: An Application to Neuroautonomic Dysfunction of Clozapine-Treated Subjects. JH Kim SH Yi YM Ahn KY Lee SA Yang YS Kim, Psychiatry Investig 2009 6 4 294 298 10.4306/pi.2009.6.4. 294 20140128
35. Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris. I Bjorkander L Forslund T Kahan M Ericson C Held N Rehnqvist P Hjemdahl, Cardiology 2008 111 2 126 133 10.1159/000119700 18376124
36. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. HV Huikuri SM Pikkujamsa KE Airaksinen MJ Ikaheimo AO Rantala H Kauma M Lilja YA Kesaniemi, Circulation 1996 94 2 122 125 8674168
37. Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. BP Kruithof SA Krawitz V Gaussin, Dev Biol 2007 302 1 208 217 10.1016/j.ydbio.2006.09.024 17054936
38. Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. TH Haapaniemi V Pursiainen JT Korpelainen HV Huikuri KA Sotaniemi VV Myllyla, J Neurol Neurosurg Psychiatry 2001 70 3 305 310 10.1136/jnnp.70.3.305 11181850 (Pubitemid 32250885)
39. Sympathetic overactivity in patients with left ventricular aneurysm in early period after anterior myocardial infarction: does sympathetic activity predict aneurysm formation? A Yildirim O Soylu B Dagdeviren A Eksik T Tezel, Angiology 2007 58 3 275 282 10.1177/0003319707302449 17626980
40. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996 17 3 354 381 8737210
41. Developmental patterns of heart rate and heart rate variability during sleep and waking in normal infants and infants at risk for the sudden infant death syndrome. RM Harper B Leake JE Hodgman T Hoppenbrouwers, Sleep 1982 5 1 28 38 7071449
42. The development of cardiac rate regulation in preweanling rats. MA Hofer MF Reiser, Psychosom Med 1969 31 5 372 388 5350296
43. Cardiac and respiratory patterns in normal infants and victims of the sudden infant death syndrome. VL Schechtman RM Harper KA Kluge AJ Wilson HJ Hoffman DP Southall, Sleep 1988 11 5 413 424 3227221
44. Heart rate variation in relation to age and sleep state in neonatal lambs. AS Siimes IA Valimaki HS Sarajas K Sakone RT Oja, Acta Physiol Scand Suppl 1984 537 7 15 6596866
45. The ontogenesis of cholinesterase activity within the heart and cardiac ganglia in man, rat, rabbit and guinea-pig. V Navaratnam, J Anat 1965 99 Pt 3 459 467 5857084
46. Ontogeny of heart-rate controls in hamster, rat, and guinea pig. EF Adolph, Am J Physiol 1971 220 6 1896 1902 5087841
47. Heier CR, DiDonato CJ: Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo. Hum Mol Genet 2009, 18(7):1310-1322